Drug intelligence / Profile preview

dyclonine hydrochloride + polyethylene glycol

Development stage
Unknown
Lead developer
Changhai Hospital
Modality
Small Molecules
Administration
Oral
01

Overview

dyclonine hydrochloride + polyethylene glycol is a combination regimen used for bowel preparation prior to colonoscopy. Dyclonine hydrochloride is a local anesthetic that, when administered as a mucilage, provides topical anesthesia to the gastrointestinal mucosa and acts as an anti-foaming agent to improve endoscopic visibility by reducing bubbles. Polyethylene glycol (PEG) is a high-molecular-weight osmotic laxative that facilitates bowel cleansing by increasing the water content and volume of the stool. This combination is being evaluated in Phase 4 clinical trials, notably at Changhai Hospital, to determine its efficacy in enhancing the adenoma detection rate (ADR) and improving the quality of bowel preparation for colorectal cancer screening.

Other names
Dyclonine Hydrochloride Mucilage + PEGDyclonine + Polyethylene GlycolDyclonine + Macrogol
02

Targets

NaV (Voltage-gated sodium channels)

Beyond the preview

Go deeper on dyclonine hydrochloride + polyethylene glycol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on dyclonine hydrochloride + polyethylene glycol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call